Baxter International Inc. (FRA:BTL)
Germany
· Delayed Price · Currency is EUR 25.97
+0.02 (0.10%)
At close: Jul 8, 2025, 10:00 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Chronic Therapies | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chronic Therapies Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medication Delivery | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medication Delivery Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Clinical Nutrition | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Clinical Nutrition Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Advanced Surgery | 1.10B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Advanced Surgery Growth | 3.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceuticals | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceuticals Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Acute Therapies | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Acute Therapies Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Patient Support Systems | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Patient Support Systems Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Surgical Solutions | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Surgical Solutions Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Front Line Care | 1.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Front Line Care Growth | -2.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Injectables and Anesthesia | 1.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Injectables and Anesthesia Growth | 0.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Drug Compounding | 1.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Drug Compounding Growth | 10.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Revenue (Post-Q2 2023 Reporting) | 67.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Revenue (Post-Q2 2023 Reporting) Growth | 76.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Infusion Therapies | 4.10B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Care & Connectivity Solutions | 1.81B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
BioPharma Solutions | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
BioPharma Solutions Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Revenue (Pre-Q3 2023 Reporting) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Revenue (Pre-Q3 2023 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | -861.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Products & Therapies Operating Income | 950.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Products & Therapies Operating Income Growth | -3.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Healthcare Systems & Technologies Operating Income | 468.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Healthcare Systems & Technologies Operating Income Growth | 12.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceuticals Operating Income | 313.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceuticals Operating Income Growth | -23.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Kidney Care Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Operating Income | 18.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Operating Income Growth | 53.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -861.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
United States | 5.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 3.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Emerging Markets | 1.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Emerging Markets Growth | -1.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World | 3.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World Growth | 4.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hillrom | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hillrom Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2011 - 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2011 - 2018 |
Americas Operating Income |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Operating Income Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA Operating Income |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA Operating Income Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC Operating Income |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC Operating Income Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hillrom Operating Income |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hillrom Operating Income Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|